Clinical trials recruiting for Focal Onset Seizures
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| SPN-817 | 2 |
| Eslicarbazepine acetate | 1 |
| XEN1101 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| Arkansas | 1 |
| California | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Michigan | 1 |
| New Jersey | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
| Oregon | 1 |
Top cities
Self-screener
Recruiting trials
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Prospective Study of Eslicarbazepine in Adults With Focal-Onset Seizures
- RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Related conditions
Trials recruiting for Focal Onset Seizures often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Focal Onset Seizures trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.